These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36346149)

  • 21. Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells.
    Leikfoss IS; Keshari PK; Gustavsen MW; Bjølgerud A; Brorson IS; Celius EG; Spurkland A; Bos SD; Harbo HF; Berge T
    PLoS One; 2015; 10(7):e0132957. PubMed ID: 26203907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression.
    Ewing E; Kular L; Fernandes SJ; Karathanasis N; Lagani V; Ruhrmann S; Tsamardinos I; Tegner J; Piehl F; Gomez-Cabrero D; Jagodic M
    EBioMedicine; 2019 May; 43():411-423. PubMed ID: 31053557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of proteome-wide and transcriptome-wide association studies identified novel genes and chemicals for vertigo.
    Cheng B; Meng P; Yang X; Cheng S; Liu L; Jia Y; Wen Y; Zhang F
    Brain Commun; 2022; 4(6):fcac313. PubMed ID: 36519156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolome-based signature of disease pathology in MS.
    Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
    Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
    Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
    Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prioritization of risk genes in multiple sclerosis by a refined Bayesian framework followed by tissue-specificity and cell type feature assessment.
    Liu A; Manuel AM; Dai Y; Zhao Z
    BMC Genomics; 2022 May; 23(Suppl 4):362. PubMed ID: 35545758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
    Andlauer TF; Buck D; Antony G; Bayas A; Bechmann L; Berthele A; Chan A; Gasperi C; Gold R; Graetz C; Haas J; Hecker M; Infante-Duarte C; Knop M; Kümpfel T; Limmroth V; Linker RA; Loleit V; Luessi F; Meuth SG; Mühlau M; Nischwitz S; Paul F; Pütz M; Ruck T; Salmen A; Stangel M; Stellmann JP; Stürner KH; Tackenberg B; Then Bergh F; Tumani H; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Arloth J; Weber P; Radivojkov-Blagojevic M; Scheinhardt MO; Dankowski T; Bettecken T; Lichtner P; Czamara D; Carrillo-Roa T; Binder EB; Berger K; Bertram L; Franke A; Gieger C; Herms S; Homuth G; Ising M; Jöckel KH; Kacprowski T; Kloiber S; Laudes M; Lieb W; Lill CM; Lucae S; Meitinger T; Moebus S; Müller-Nurasyid M; Nöthen MM; Petersmann A; Rawal R; Schminke U; Strauch K; Völzke H; Waldenberger M; Wellmann J; Porcu E; Mulas A; Pitzalis M; Sidore C; Zara I; Cucca F; Zoledziewska M; Ziegler A; Hemmer B; Müller-Myhsok B
    Sci Adv; 2016 Jun; 2(6):e1501678. PubMed ID: 27386562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.
    Campagna MP; Xavier A; Stankovich J; Maltby VE; Slee M; Yeh WZ; Kilpatrick T; Scott RJ; Butzkueven H; Lechner-Scott J; Lea RA; Jokubaitis VG
    Clin Epigenetics; 2023 Feb; 15(1):20. PubMed ID: 36765422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis.
    Scapoli C; Ziliotto N; Lunghi B; Menegatti E; Salvi F; Zamboni P; Baroni M; Mascoli F; Bernardi F; Marchetti G
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Architecture of the Cardiovascular Risk Proteome.
    Benson MD; Yang Q; Ngo D; Zhu Y; Shen D; Farrell LA; Sinha S; Keyes MJ; Vasan RS; Larson MG; Smith JG; Wang TJ; Gerszten RE
    Circulation; 2018 Mar; 137(11):1158-1172. PubMed ID: 29258991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis.
    Marchetti G; Ziliotto N; Meneghetti S; Baroni M; Lunghi B; Menegatti E; Pedriali M; Salvi F; Bartolomei I; Straudi S; Manfredini F; Voltan R; Basaglia N; Mascoli F; Zamboni P; Bernardi F
    Mol Med; 2018 Aug; 24(1):42. PubMed ID: 30134823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irrespective of Plaque Activity, Multiple Sclerosis Brain Periplaques Exhibit Alterations of Myelin Genes and a TGF-Beta Signature.
    Nataf S; Guillen M; Pays L
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Chan MY; Efthymios M; Tan SH; Pickering JW; Troughton R; Pemberton C; Ho HH; Prabath JF; Drum CL; Ling LH; Soo WM; Chai SC; Fong A; Oon YY; Loh JP; Lee CH; Foo RSY; Ackers-Johnson MA; Pilbrow A; Richards AM
    Circulation; 2020 Oct; 142(15):1408-1421. PubMed ID: 32885678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.
    Ma Q; Caillier SJ; Muzic S; ; Wilson MR; Henry RG; Cree BAC; Hauser SL; Didonna A; Oksenberg JR
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34911760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.
    Folkersen L; Fauman E; Sabater-Lleal M; Strawbridge RJ; Frånberg M; Sennblad B; Baldassarre D; Veglia F; Humphries SE; Rauramaa R; de Faire U; Smit AJ; Giral P; Kurl S; Mannarino E; Enroth S; Johansson Å; Enroth SB; Gustafsson S; Lind L; Lindgren C; Morris AP; Giedraitis V; Silveira A; Franco-Cereceda A; Tremoli E; ; Gyllensten U; Ingelsson E; Brunak S; Eriksson P; Ziemek D; Hamsten A; Mälarstig A
    PLoS Genet; 2017 Apr; 13(4):e1006706. PubMed ID: 28369058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of alternative splicing variants in multiple sclerosis - A systematic review.
    Hecker M; Rüge A; Putscher E; Boxberger N; Rommer PS; Fitzner B; Zettl UK
    Autoimmun Rev; 2019 Jul; 18(7):721-732. PubMed ID: 31059848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The genetics of multiple sclerosis. A review.
    Kalman B; Lublin FD
    Biomed Pharmacother; 1999 Sep; 53(8):358-70. PubMed ID: 10554670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
    Posavi M; Diaz-Ortiz M; Liu B; Swanson CR; Skrinak RT; Hernandez-Con P; Amado DA; Fullard M; Rick J; Siderowf A; Weintraub D; McCluskey L; Trojanowski JQ; Dewey RB; Huang X; Chen-Plotkin AS
    PLoS Med; 2019 Oct; 16(10):e1002931. PubMed ID: 31603904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis.
    Kiryluk K; Li Y; Sanna-Cherchi S; Rohanizadegan M; Suzuki H; Eitner F; Snyder HJ; Choi M; Hou P; Scolari F; Izzi C; Gigante M; Gesualdo L; Savoldi S; Amoroso A; Cusi D; Zamboli P; Julian BA; Novak J; Wyatt RJ; Mucha K; Perola M; Kristiansson K; Viktorin A; Magnusson PK; Thorleifsson G; Thorsteinsdottir U; Stefansson K; Boland A; Metzger M; Thibaudin L; Wanner C; Jager KJ; Goto S; Maixnerova D; Karnib HH; Nagy J; Panzer U; Xie J; Chen N; Tesar V; Narita I; Berthoux F; Floege J; Stengel B; Zhang H; Lifton RP; Gharavi AG
    PLoS Genet; 2012; 8(6):e1002765. PubMed ID: 22737082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets.
    Dong Z; Ma Y; Zhou H; Shi L; Ye G; Yang L; Liu P; Zhou L
    BMC Pulm Med; 2020 Oct; 20(1):270. PubMed ID: 33066754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.